2011 - ISBTS 2011 Symposium


This page contains exclusive content for the member of the following sections: TTS, ITA. Log in to view.

Oral Communications 15: Indications

20.311 - Timing of intestinal/multivisceral transplant for Gardner’s syndrome on adults: review of a single center experience

Presenter: Augusto, Lauro, Bologna, Italy
Authors: Augusto Lauro1, Chiara Zanfi1, Sara Pellegrini1, Fausto Catena1, Loris Pironi1, Antonio Pinna1

311
Timing of intestinal/multivisceral transplant for Gardner’s syndrome on adults: review of a single center experience

Augusto Lauro, Chiara Zanfi, Sara Pellegrini, Fausto Catena, Loris Pironi, Antonio Pinna

S. Orsola Hospital - Liver and Multiorgan Transplant Center, Bologna, Italy

Aim: Patients affected by Gardner’s Syndrome are subjected to death at young age, usually after multiple abdominal surgeries. Nowadays alternative therapies other than surgery are uneffective and abdominal evisceration followed by TPN seems to be the mean for a long term survival. Unfortunately recent studies showned a lower survival of these patients under TPN treatment comparing to standard TPN- patients. Transplantation seems to be an alternative. We review our experience regarding intestinal transplantation for Gardner’s Syndrome.

Subjects and Methods: Average waiting  time in our list for transplantation was 259 days: we registered 1 death in list before transplant. Actually we have in list  5 patients for Gardner’s syndrome, the oldest since 2005. Eleven patients were transplanted in our center: 9 were on TPN at time of transplant;when evisceration was performed , average size of  desmoid tumors was greater than 10 cm in 9 patients (in two remaining cases the procedure was performed elsewhere).

Results: Average age at transplant was 34 years. Five patients were transplanted with a multivisceral graft, 6 with isolated small bowel: immunosuppression was represented by FK regimen plus induction with Alemtuzumab in 10 cases, 1 case was treated with Daclizumab. Two patients survived up to now: causes of death were: infections in 7 cases, tumor recurrence in 1 case and intraoperative death in last case. Considering the 9 deaths, 5  patients received an isolated graft while 4 a multivisceral one  (one recipient with liver), one of them was a re-transplant. Average survival after transplant is of 449 days. One survived patient has a desmoid intra-abdominal recurrence.

Conclusions: An early referral for a life-saving intestinal/multivisceral transplant should be considered for patients with desmoids: patients should be referred for listing to transplant centers at time of diagnosis, before TPN and  growth of invasive intra-abdominal desmoids tumors. 


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada